Information for Radiologic Technologists
Questions about this year's conference? Call (802) 656-2292.
- Please register for the conference by 8:00 am on September 28, 2015. Walk-ins are welcome after the registration deadline. However, space is limited and some sessions may be closed. Register early!
- The conference will be held at the Sheraton Burlington Hotel & Conference Center in South Burlington, Vermont.
- The conference opens at 8:00 am with over 60 exhibits in the Exhibit Hall.
- Sessions begin at 9:00 am and end at 4:05 pm.
- The sessions and exhibits are free due to the generous support of the Susan G. Komen for the Cure Vermont-New Hampshire Affiliate, The University of Vermont College of Medicine, the University of Vermont Medical Center, and Seventh Generation.
The 18th Annual Women's Health and Breast Cancer Conference will have several sessions available for Radiologic Technologist CE Credit. The sessions below all offer RT credit for attendance.
Session One (9:00-9:50 AM)
1-2: Predictors of Recurrence After a DCIS Diagnosis / Brian Sprague, PhD / This session will discuss the basic biology of DCIS (ductal carcinoma in situ, the most common type of non-invasive breast cancer) and the magnitude of this diagnosis as a public health problem; the typical disease-free survival rates for DCIS, including the average time from diagnosis to an invasive breast cancer diagnosis; and predictors of disease-free survival, including factors related to the patient, her treatments, and the characteristics of the DCIS diagnosis.
1-3: Colorectal Cancer: Are You or a Loved One at Risk? / For both men and women, colorectal cancer is one of the most common forms of cancer. This session will provide you with an overview of the subject, ways to reduce your risk, and screening choices that are available to you.
1-4: Mammography in 3-D: Coming Soon to a Breast Center Near You / Rebecca Zuurbier, MD / This talk will describe the evolving role of 3-D Tomosynthesis in breast cancer detection and diagnosis. The technology and technique will be described and the current research will be reviewed. Practical implications for the patient, radiologist and referring provider will be considered.
1-9 I Helped Find a Cure: How Clinical Trials Change Lives / Claire Verschraegen, MD / Clinical trials are one of the most essential tools in finding new breakthroughs for cancer treatment. This panel will answer your questions about clinical trials and let you know how you can help find a cure.
Session Two (10:00-10:50 AM)
2-1: Genetic Counseling and Testing for Inherited Cancer Risk / Wendy McKinnon, MS, CGC / This session will review the features of inherited cancers that impact women (breast, ovarian and endometrial) and explain who might be a candidate for referral for cancer risk assessment, genetic counseling and possibly genetic testing. This talk will review what happens during a genetic counseling session, as well as review the risks, benefits and limitations of undergoing genetic testing for cancer risk.
2-4: Therapeutic Targeting of Anti-Estrogen-Resistant ER+ Breast Cancer / Todd Miller, PhD / Patients with estrogen receptor (ER)-positive breast
cancer are typically treated with anti-estrogen therapy
for 5-10 years after surgical removal of a primary tumor. However, one third of these patients develop antiestrogen-resistant advanced/metastatic breast cancer that is rarely cured with existing therapies. Knowledge gained from breast cancer cells and animal models is being actively translated into early-phase clinical trials to develop more effective strategies to prevent cancer recurrence and manage metastatic disease.
2-5: Ovarian Cancer Screening / Elise Everett, MD /The recommendations for ovarian cancer screening can vary depending on your risk factors and medical history. This session will provide a better understanding of the data behind these and help you make choices that are right for you.
2-6: What's Density Got to Do With It? Breast Density and How it Affects Screening for You and Your Patients / Sally Herschorn, MD / Having dense breasts is the number one reason cancers are missed on mammograms. Up to 50% of women have dense breasts. Breast density is also a risk factor for breast cancer. If you have dense breasts you belong to a very big club. This talk will explain what breast density means for the patient and her provider and the options available to improve screening.
2-8: Patient Navigation and Resources for the Cancer Patient / Susan Bouffard, RN / Patient navigation is becoming more and more common and will soon be an essential part of cancer care. This session is targeted toward those who are interested in the navigation process and how navigation can help patients facing a cancer diagnosis.
Session Three (11:00-11:50 AM)
3-1: Genetic Testing and Inherited Breast and Ovarian Cancer: Patient Perspectives / Wendy McKinnon, MS / This panel discussion includes several individuals who have undergone genetic counseling and testing for the BRCA1/BRCA2 genes. These two genes are associated with the majority of inherited breast and ovarian cancers. There will be a variety of results and a range of perspectives on the testing process. Anyone interested in learning more about the BRCA1/BRCA2 counseling and testing process is encouraged to attend.
3-5: Ovarian Cancer Treatments / Elise Everett, MD / This session will discuss the treatments used for ovarian cancer at various stages, side effect management, and research for new therapies. Attendees will leave this session with a better understanding of the role of surgery, chemotherapy, and new biological agents in the treatment of ovarian cancer.
3-8: What to Expect When You Get Called Back From Your Routine Screening Mammogram / Elise Hotaling, MD / Approximately 10% of patients undergoing a screening mammogram are called back to further evaluate a finding seen on the initial images. Such findings may include calcifications, densities, and masses, any one of which may be a sign of benign or malignant disease. This presentation discusses the tools breast imagers use to complete this additional evaluation and what you can expect as a result.
Lunch Sessions (12:00-1:00 PM)
L-4 Radiology-Pathology Correlation of Selected Breast Imaging / Robert Oppenheimer, MD / This session will present cases reviewing mammography, ultrasound, and MRI findings leading to eventual
biopsy and histologic confirmation of both benign and malignant breast lesions. A discussion of work-up algorithms will also be presented. This session is geared toward radiologic technologists and providers.
Session Four (1:15-2:05 PM)
4-7: The Benefits of Weight Loss in Cancer / Kim Dittus, MD, PhD / Weight gain is common in breast cancer
patients after diagnosis and during treatment.
Unfortunately, survivors who are overweight may
be more likely than trimmer survivors to have their cancer recur. This workshop reviews why weight is likely to change during treatment and details activities you can do that have consistently been shown to reduce the risk of breast cancer, improve odds of survival if diagnosed, and help prevent other illnesses.
4-9: The Role of Nutrition and Supplements in Cancer Treatment / Andrea Fossati, MD / This session will provide helpful hints for the management of common side effects of chemotherapy, including taste changes, nausea, and constipation. Patients and health care providers will find strategies for optimal tolerance of treatment and preservation of quality of life. Additionally, focus will be placed on the maintenance of one’s nutritional status to ensure treatment can be continued uninterrupted and aid in healing.
Session Five (2:15-3:05 PM)
5-3: A Multidisciplinary Approach to Breast Cancer Diagnosis and Treatment / Maureen Harmon, MD, Deborah Rubin, MD, Mary Stanley, MD, Erin Tsai, MD, and Paul Unger, MD / Current breast cancer care involves the coordination of multiple medical disciplines: surgery, pathology, radiology, and specialists in chemotherapy and radiation treatment. In this session you will sit in on a reenactment of a weekly breast cancer case conference where specialists review clinical, radiologic, and pathologic findings of patients recently diagnosed with breast cancer and discuss the best approaches to treatment.
5-8: What’s New in Breast Cancer Reconstruction? / Robert Nesbit, MD / In this session, we will focus on newer techniques for reconstruction after breast cancer surgery. Some of the techniques discussed may include oncoplastic surgery after lumpectomy, nipple sparing mastectomy, and new technologies that may improve reconstructive outcomes.
5-10: PROVIDER TRACK: The Many Benefits of Palliative Care as a Part of a Comprehensive Cancer Team / Jonna Goulding, MD / Palliative care is an essential piece of treatment about which many providers need to know more. This session will discuss palliative treatments from a provider’s standpoint and give a comprehensive discussion on how every provider can benefit from knowing more about this field. This session is specifically geared toward primary care providers and other health care professionals. Please note that this session will run until 3:15 pm.
Session Six (3:15-4:05 PM)
6-1: What to Do If You Find a Lump / Ted James, MD / This session will describe what women and their health care providers should do if they are faced with a situation where they find a lump in their breast. Information about signs of breast cancer, approaches to making a diagnosis and treatment considerations for a confirmed breast cancer will be discussed. Participants will learn how to improve their ability to navigate the health care system to optimize quality and outcomes when dealing with a breast-related problem.
6-2: Breast Lymphedema / Kristi Johnson, PT, CLT-LANA / This session will cover the myths and mysteries of lymphedema specifically related to breast edema. Learning objectives are to obtain a basic understanding of: the lymphatic system, breast related lymphedema, risks and precautions, as well as some treatment options.
6-3: What’s New in Radiation Oncology / Rick Lovett, MD / This session discusses the principles of radiation and how tissue sparing is accomplished, the new advances in radiation treatments, and how individualized radiation treatments are designed..
6-5: Oncology Rehabilitation: Steps to Wellness / Kim Dittus, MD, PhD, Britta Nelson, BS, Diane Stevens, PT / Steps to Wellness is a comprehensive Oncology Rehab program for cancer survivors. The components of this evidenced-based exercise program will be presented by the team providing this service. It is also a research program and current research findings including implications for exercise recommendations will be presented. Fitness, strength, balance, and mobility can all be affected by cancer and cancer treatments. How a structured exercise program can improve these areas will be addressed. Individuals interested in joining the program will find the overview helpful as well as professionals wishing to expand their own cancer survivorship knowledge in the area of exercise.
Interested in attending? Register now!
Last modified August 17 2015 01:26 PM